Davis Polk, Goodwin Steer Pharma Deal Worth Up To $2.1B
Global health care company Novo Nordisk said Thursday it will pay up to $2.1 billion to acquire clinical-stage therapeutics company Corvidia Therapeutics, in a deal put together with guidance from Davis...To view the full article, register now.
Already a subscriber? Click here to view full article